Literature DB >> 16979267

No association of chromatin-modifying protein 2B with sporadic frontotemporal dementia.

Axel Schumacher1, Patricia Friedrich, Janine Diehl-Schmid, Bernd Ibach, Tamara Eisele, Simon M Laws, Hans Förstl, Alexander Kurz, Matthias Riemenschneider.   

Abstract

Mutations of the chromatin modifying protein 2B gene (CHMP2B) were identified, in a Danish pedigree, to cause familial frontotemporal dementia (FTD). To explore the possible genetic contribution of common CHMP2B variants in sporadic FTD, we analyzed 14 single nucleotide polymorphisms covering the entire genomic region of CHMP2B. After adjustment for multiple testing single marker and haplotype analysis revealed no significant association with sporadic FTD. Thus, we conclude that CHMP2B can be excluded as a susceptibility gene conferring risk to sporadic forms of FTD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16979267     DOI: 10.1016/j.neurobiolaging.2006.07.016

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  3 in total

Review 1.  FTD and ALS: a tale of two diseases.

Authors:  R Ferrari; D Kapogiannis; E D Huey; P Momeni
Journal:  Curr Alzheimer Res       Date:  2011-05       Impact factor: 3.498

Review 2.  Frontotemporal dementia: latest evidence and clinical implications.

Authors:  Juan Joseph Young; Mallika Lavakumar; Deena Tampi; Silpa Balachandran; Rajesh R Tampi
Journal:  Ther Adv Psychopharmacol       Date:  2017-11-10

3.  Novel missense mutation in charged multivesicular body protein 2B in a patient with frontotemporal dementia.

Authors:  Raffaele Ferrari; Dimitrios Kapogiannis; Edward D Huey; Jordan Grafman; John Hardy; Parastoo Momeni
Journal:  Alzheimer Dis Assoc Disord       Date:  2010 Oct-Dec       Impact factor: 2.703

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.